Copyright
©The Author(s) 2019.
World J Gastroenterol. Dec 28, 2019; 25(48): 6928-6938
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6928
Published online Dec 28, 2019. doi: 10.3748/wjg.v25.i48.6928
Figure 1 Comparison between Short-Form-36 domains of controls and patients before and after hepatitis C virus eradication.
HCV: Hepatitis C virus; DAAs: Directly acting antivirals; MCS: Mental component summary; PCS: Physical Component Summary.
Figure 2 Pearson’s correlations between each neuropsychological test and mental component summary of Short-Form-36 at basal evaluation.
MCS: Mental component summary.
Figure 3 Pearson’s correlations between the variations of Zung-Self Depression Rating Scale, Toronto-Alexithymia Scale-20, Spielberg State-Trait Anxiety Inventory Y1 and Spielberg State-Trait Anxiety Inventory Y2 and the variation of mental component summary before and after Hepatitis C virus eradication.
TAS-20: Toronto-Alexithymia Scale-20; Zung-SDS: Zung-Self Depression Rating Scale; MCS: Mental component summary; STAI-Y1: Spielberg State-Trait Anxiety Inventory Y1; STAI-Y2: Spielberg state-Trait Anxiety Inventory Y2.
- Citation: Nardelli S, Riggio O, Rosati D, Gioia S, Farcomeni A, Ridola L. Hepatitis C virus eradication with directly acting antivirals improves health-related quality of life and psychological symptoms. World J Gastroenterol 2019; 25(48): 6928-6938
- URL: https://www.wjgnet.com/1007-9327/full/v25/i48/6928.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i48.6928